Skip to content
DataLookout
Menu

aSVF-DORNCT07901218

Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Diminished Ovarian Reserve

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 1 with changes below, 1 re-verified with no change.

  1. Study First Submitted

Endpoints

Primary

The cumulative clinical pregnancy rate within 6 months in women with DOR undergoing IVF
Timeframe: Within 6 months after treatment

Secondary (8)

Serum level of Anti-Mullerian hormone (AMH)
Antral follicles count (AFC)
Serum level of sex hormone (E2 and FSH)
Ovarian volume
Menstrual status
Show 3 moreShow less
Pregnancy outcomes
Health status of offspring
Adverse events (AEs)

Arms and interventions

Group A-SVF groupExperimental

Qualified participants will be randomized into either of two groups. Participants in this group will undergo lower abdominal liposuction, preparation of SVF and ovarian injection, other standard assisted reproductive treatments are similar and parallel between two groups. In addition, if necessary, oral administration of hormones such as Fenbolone can be given for replacement therapy.

Group B-Control groupActive comparator

Qualified participants will be randomized into either of two groups. Participants in this group will be treated according to the current clinical routine of the reproductive center, other standard assisted reproductive treatments are similar and parallel between two groups. In addition, if necessary, oral administration of hormones such as Fenbolone can be given for replacement therapy.

Procedures: Lower abdominal liposuction and preparation of SVF, Ovarian injection, Conventional ART treatment

Drugs: Hormone Replacement Therapy (HRT)

Sites

4 sites in 1 country